FDA eyes US Smokeless Tobacco Modified Risk Tobacco Product application

U.S. Smokeless Tobacco, a wholly-owned subsidiary of Altria Group, announced that the FDA accepted and filed for substantive scientific review a Modified Risk Tobacco Product application for its moist smokeless tobacco product Copenhagen Snuff Fine Cut. The application requests FDA authorization to make one claim: “IF YOU SMOKE CONSIDER THIS: Switching completely to this product from cigarettes reduces risk of lung cancer.” The Agency will begin a substantive scientific review process, which includes opportunities for public comment.
https://thefly.com/landingPageNews.php?id=2790763